These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23401897)

  • 1. Diagnosis and management of von Willebrand disease.
    Federici AB; Mannucci PM
    Haemophilia; 1999 May; 5 Suppl 2():28-37. PubMed ID: 23401897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the diagnosis and management of von Willebrand disease in Italy.
    Federici AB; Castaman G; Mannucci PM;
    Haemophilia; 2002 Sep; 8(5):607-21. PubMed ID: 12199668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the genetics and treatment of von Willebrand disease.
    Federici AB; Mannucci PM
    Curr Opin Pediatr; 2002 Feb; 14(1):23-33. PubMed ID: 11880730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of inherited von Willebrand disease.
    Mannucci PM; Federici AB
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):455-62. PubMed ID: 11686109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of von Willebrand disease.
    Mannucci PM
    Haemophilia; 1998 Jul; 4(4):661-4. PubMed ID: 9873811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of von Willebrand disease.
    Federici AB
    Haemophilia; 1998 Jul; 4(4):654-60. PubMed ID: 9873810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing therapy with factor VIII/von Willebrand factor concentrates in von Willebrand disease.
    Federici AB; Mannucci PM
    Haemophilia; 1998; 4 Suppl 3():7-10. PubMed ID: 10028312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
    Federici AB
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial.
    Mannucci PM; Tenconi PM; Castaman G; Rodeghiero F
    Blood; 1992 Jun; 79(12):3130-7. PubMed ID: 1596562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild forms of von Willebrand disease: diagnosis and management.
    Federici AB
    Curr Hematol Rep; 2003 Sep; 2(5):373-80. PubMed ID: 12932308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of inherited von Willebrand disease in 2006.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):616-20. PubMed ID: 16977571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perioperative therapy of von Willebrand disease. Demonstration of pathophysiology, clinical problems and therapy options using two case reports].
    Kleinschmidt S; Fuchs-Buder T; Wilhelm W; Seyfert UT; Mörsdorf S
    Anaesthesist; 2002 Oct; 51(10):825-34. PubMed ID: 12395174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.